Hypolipidemic and Antioxidant Effects of Black Tea Extract and Quercetin in Atherosclerotic Rats

Authors: Wahyu Widowati, Hana Ratnawati, Tjandrawati Mozefis, Dwiyati Pujimulyani, Yelliantty Yelliantty

Abstract:

Background: Atherosclerosis is the main cause of cardiovascular disease (CVD) with complex and multifactorial process including atherogenic lipoprotein, oxidized low density lipoprotein (LDL), endothelial dysfunction, plaque stability, vascular inflammation, thrombotic and fibrinolytic disorder, exercises and genetic factor Epidemiological studies have shown tea consumption inversely associated with the development and progression of atherosclerosis. The research objectives: to elucidate hypolipidemic, antioxidant effects, as well as ability to improve coronary artery’s histopathologyof black tea extract (BTE) and quercetin in atherosclerotic rats. Methods: The antioxidant activity was determined by using Superoxide Dismutase activity (SOD) of serum and lipid peroxidation product (Malondialdehyde) of plasma and lipid profile including cholesterol total, LDL, triglyceride (TG), High Density Lipoprotein (HDL) of atherosclerotic rats. Inducing atherosclerotic, rats were given cholesterol and cholic acid in feed during ten weeks until rats indicated atherosclerotic symptom with narrowed artery and foamy cells in the artery’s wall. After rats suffered atherosclerotic, the high cholesterol feed and cholic acid were stopped and rats were given BTE 450; 300; 150 mg/kg body weight (BW) daily, quercetin 15; 10; 5 mg/kg BW daily, compared to rats were given vitamin E 60 mg/kg/BW; simvastatin 2.7 mg/kg BW, probucol 30 mg/kg BW daily for 21 days (first treatment) and 42 days (second treatment), negative control (normal feed), positive control (atherosclerotic rats). Results: BTE and quercetin could lower cholesterol total, triglyceride, LDL MDA and increase HDL, SOD were comparable with simvastatin, probucol both for 21 days and 42 days treatment, as well to improve coronary arteries histopathology. Conclusions: BTE andquercetin have hypolipidemic and antioxidant effects, as well as improve coronary arteries histopathology in atherosclerotic rats.

Keywords: Black tea, quercetin, atherosclerosis, antioxidant, hypolipidemic, cardiovascular disease.

Digital Object Identifier (DOI): doi.org/10.5281/zenodo.1088148

References:

[1] Tavridou A, Manolopoulos VG. 2008. Novel molecules targeting dyslipidemia and atherosclerosis. Curr Med Chemi; 15:792-802
[2] Vasdev S, Gill V, singal PK. 2006. Beneficial effect of low ethanol intake on the cardiovascular system: possible biochemical mechanisms. Vasc Health Risk Manage;:2(3) 263–276.
[3] Roy H, Bhardwaj S, Yla-Herttuala S. 2009. Molecular genetics of atherosclerosis. Hum Genet 125:467–491.
[4] Jain K S, Kathiravan M K, Somani RS, Shishoo C J, Bioorg. 2007. Med Chem; 15:4674.
[5] Chan JC, Cheung JC, Stehouwer CD, Emeis JJ, Tong PC, Ko GT, Yudkin JS. 2002. The central roles of obesity associated dyslipidaemia, endothelial activation and cytokines in the metabolic syndrome: an analysis by structural equation modeling. Int J Obes Relat Metab Disord; 26(7):994–1008
[6] Duchnowicz P, Broncel B, Podse˛dek A, Koter-Michalak M. 2012. Hypolipidemic and antioxidant effects of hydroxycinnamic acids, quercetin, and cyanidin 3-glucoside in hypercholesterolemic erythrocytes (in vitro study). Eur J Nutr; 51:435–443 DOI 10.1007/s00394-011-0227-y
[7] Stocker R, Keaney JF Jr. 2004. Role of oxidative modifications in atherosclerosis. Physiol Rev; 84:1381-1478.
[8] Mukamal KJ, Maclure M, Muller JE, Sherwood JB, Mittleman M.A. 2002. Tea consumption and mortality after acute myocardial infarction. Circulation; 105:2476-2481
[9] Knekt P, Jarvinen R, Reunanen A, Maatela J. 1996. Flavonoid intake and coronary mortality in Finland: a cohort study. BMJ; 312:478–481
[10] Geleijnse JM, Launer LJ, van der Kuip DAM, Hofman A, Witteman JCM. 2002. Inverse association of tea and flavonoid intakes with incident myocardial infarction: the Rotterdam Study. Am J Clin Nutr; 75(5):880-886
[11] Leenen R, Roodenburg AJ, Tijburg LB, Wiseman SA. 2000. A single dose of tea with or without milk increases plasma antioxidant activity in humans. Eur J Clin Nutr; 54:87–92
[12] Bliss RM. 2003. Brewing up the latest tea research. Agric Res; 51:10-13.
[13] Carlson, JR, Bauer Vincent A, Limburg PJ, Wilson T. 2007. Reading the tea leaves: anticarcinogenic properties of (-)-Epigallocatechin-3-Gallate. Mayo Clinic Proceedings; 82(6):725-732
[14] Frei B, Hidgon JV. 2003. Antioxidant activity of tea polyphenols in vivo: evidence from animal studies. J Nutr;133:3275S-3284S.
[15] Ransod Superoxide dismutase. RANDOX Laboratories Ltd., Ardmore, Diamond Road, Crumlin, Co. Antrim, United Kingdom, BT29 4QY.
[16] Ohkawa H,Ohishi N,Yagi K. 1979. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem; 95:351-358.
[17] Jeong WI, Jeong, DH, Do, SH, Kim, YK, Park, HY, Kwon, OD, Kim, TH, Jeong, KS. 2005 Mild hepatic fibrosis in cholesterol and sodium cholate diet-fed rats. J Vet MedSci; 67:235-242
[18] Horton JD, Cuthbert JA, Spady DK. 1995. Regulation of hepatic 7 alpha-hydroxylase expression and response to dietary cholesterol in the rat and hamster. J Biol Chem; 270:5381-5387
[19] Pellizzon MA. 2008. Diet- induced atherosclerosis/hypercholesterolemia in rodent models. Res Diets. 1-3
[20] Daley SJ, Klemp KF, Guyton JR, Rogers KA. 1994. Cholesterol-fed and casein-fed rabbit models of atherosclerosis. Part 2: Differing morphological severity of atherogenesis despite matched plasma cholesterol Cholesterol-fed and casein-fed rabbit models of atherosclerosis levels. Arterioscler Thromb Vasc Biol;14;105-141
[21] Tavridou A, Efthimiadis A, Efthimiadis I, Manolopoulos VG. 2010. Simvastatin-induced changes in circulating oxidized low-density lipoprotein in different types of dyslipidemia. Heart Vessels; 25:288– 293. DOI 10.1007/s00380-009-1202-x
[22] Davies MJ, Judd JT, Baer DJ, Clevidence BA, Paul DR, Edwards AJ, Wiseman SA, Muesing RA, Chen SC. 2003. Black tea consumption reduces total and ldl cholesterol in mildly hypercholesterolemic adults. J Nutr; 133:3298S–3302S
[23] Sesso HD, Gaziano JM., Buring JE, Hennekens CH. 1999. Coffee and Tea Intake and the Risk of Myocardial Infarction. Am J Epidemiol; 149:162-167
[24] Serafini M, Ghiselli A, Ferro-Luzzi A. 1996. In vivo antioxidant effect of green and black tea in man.Eur. J Clin Nutr; 50:79-85
[25] Vinson JA, Teufel K, Wu N. 2004. Green and black teas inhibit atherosclerosis by lipid, antioxidant, and fibrinolytic mechanisms. J Agric Food Chem. 52(11):3661-5.
[26] Yang M, Wang C, Chen H. 2001. Green, oolong and black tea extracts modulate lipid metabolism in hyperlipidemia rats fed high-sucrose diet. J Nutr Biochem; 12(1):14-20.
[27] Shrestha S, Ehlers SJ, Lee JY, Fernandez ML, Koo SI. 2009. Dietary green tea extract lowers plasma and hepatic triglycerides and decreases the expression of sterol regulatory element-binding protein-1c mrna and its responsive genes in fructose-fed, ovariectomized rats. J Nutr; 139(4):640-645.
[28] Muramatsu K, Fukuyo M, Hara Y. 1986. Effect of green tea catechins on plasma cholesterol level in cholesterol-fed rats. J Nutr Sci Vitaminol; 32(6):613-622.
[29] Matsumoto N, Okushio K, Hara Y. 1998. Effect of black tea polyphenols on plasma lipids in cholesterol-fed rats. J Nutr Sci Vitaminol; 44: 337–342.
[30] Yang CS, Landau JM. 2000. Effects of tea consumption on nutrition and health. J Nutr; 130:2409-2412.
[31] Kono S, Shinchi K, Wakabayashi K, Honjo S, Todoroki I, Sakurai Y, Imanishi K, Nishikawa H, Ogawa S, Katsurada M. 1996. Relation of green tea consumption to serum lipids and lipoproteins in Japanese men. J Epidemiol; 6(3):128-33.
[32] Raederstoff DG, Schlachter MF, Elste V, Weber P. 2003. Effect of EGCG on lipid absorption and plasma lipid levels in rats. J Nutr Biochem; 14:326–332.
[33] Cabrera C, Artacho R, Gime´nez R. 2006. Beneficial effects of green tea—a review. J Am Coll Nutr; 25(2):79–99
[34] Chan PT, Fong WP, Cheung, YL, Huang Y, Ho WKK,Chen Z-Y. 1999. Jasmine green tea epicatechins are hypolipidemic in hamsters (Mesocricetus auratus) fed a high fat diet. J Nutr; 129:1094–1101.
[35] Nagao T, Komine Y, Soga S, Meguro S, Hase T, Tanaka Y, Tokimitsu I. 2005. Ingestion of a tea rich in catechins leads to a reduction in body fat and malondialdehyde-modified LDL in men. Am J Clin Nutr; 81:122– 129.
[36] Maron D J, Lu GP, Cai NS, Wu ZG, Li Y H, Chen H, Zhu JQ, Jin XJ, Wouters BC, Zhao J. 2003. Cholesterol-lowering effect of a theaflavin-enriched green tea extract: a randomized controlled trial. Arch Int Med;163: 1448-1453
[37] Judd JT, Davies MJ, Baer DJ, Chan SC, Wiseman S, Agarwal S. 2003. Black tea consumption reduces total and LDLcholesterol in mildly hypercholesterolemic subjects. J. Nutr; 133: 3298S-3302S
[38] Reaven PD, Witztum JL 1996. Oxidized low density lipoproteins in atherogenesis: role of dietary modification. Ann Rev Nutr; 16: 51–71
[39] Libby P, Ridker PM, Hansson GK. 2011. Progress and challenges in translating the biology of atherosclerosis. Nat; 473:317-325 doi:10.1038/nature10146
[40] Loke WM, Proudfoot JM, Hodgson JM, McKinley AJ, Hime N, Magat, Stocker R, Croft KD. 2010. Specific dietary polyphenols attenuate atherosclerosis in apolipoprotein e–knockout mice by alleviating inflammation and endothelial dysfunction. Arterioscler Thromb Vasc Biol; 30:749-757
[41] Fki I, Bouaziz M, Sahnoun Z, Sayadi S. 2005. Hypocholesterolemic effects of phenolic-rich extracts of Chemlali olive cultivar in rats fed a cholesterol-rich diet. BioorgMed Chem; 3: 5362–5370
[42] Kaur GK, Meena C. 2013. Evaluation of anti-hyperlipidemic poptential of combinatioral extract of curcumin, piperine and quercetin in tritoninduced hyperlipidemia in rats. Sci Int; 1(3):57-63.
[43] Rivera L, Moron R, sanchez M, Zarzuelo A, Galisteo M. 2008, Quercetin ameliorates metabolic syndrome and improves the inflammatory status in obese zucker rats. Obesity 16:2081–2087
[44] Shin HS, Yoo JH, Min TS, Lee K-Y, Choi CY. 2010. The effects of quercetin on physiological characteristics and oxidative stress resistance in olive flounder, paralichthys olivaceus. Asian-Aust J Anim Sci; 23(5):588-559
[45] Widowati W, Herlina T, Ratnawati H, Mozef T, Risdian T. 2011. Antioxidant and platelet aggregation inhibitor activities of black tea (Camellia sinensis L.) extract and fractions. Med Plants; 3(1) : 21-26.
[46] Sung H, Min WK., Lee W, Chun S, Park H, Lee Y-W, Jang S, Lee D-H. 2005. The effects of green tea ingestion over four weeks on atherosclerotic markers. Ann Clin Biochem; 42:292–297
[47] Yang TT, Koo MW. 1997. Hypocholesterolemic effects of Chinese tea. Pharmacol Res Jun;35(6):505-12.
[48] Basu A, Lucas EA. 2007. Mechanisms and effects of green tea on cardiovascular health. Nutr Rev; 65(8):361-375
[49] Bhaskar S, Kumar KS, Krishnan K, Antony H. 2013. Quercetin alleviates hypercholesterolemic diet induced inflammation during progression and regression of atherosclerosis in rabbits. Nutr; 29(1):219- 229. doi: 10.1016/j.nut.2012.01.019
[50] Terao J, Kawai Y, Murota K. 2008. Vegetable flavonoids and cardiovascular disease. Asia Pac J Clin Nutr; 17(S1):291-293
[51] Moon JH, Tsushida T, Nakahara K, Terao J. 2001. Identification of quercetin 3-O-β-glucuronide as an antioxidative metabolite in rat plasma after oral administration of quercetin. Free Radical Biol Med; 30:1274- 1285
[52] Ohara Y, Peterdon TE, Harrison DG. 1993. Hyper-cholesteroemia increases endothelial superoxide anion production. J Clin Invest; 91:2546-2551.
[53] Williamson G, Barron D, Shimoi K, Terao J. 2005. In vitro biological properties of flavonoid conjugates found in vivo. Free Radical Res; 39:457-69
[54] USDA. 2003. USDA Database for the Flavonoid Contents of Selected Foods. Beltsville: US Department of Agriculture.
[55] Bors W, Saran M. 1987. Radical scavenging by flavonoid antioxidants. Free Radic Res Commun; 2:289-294
[56] Chen Y-H, Li S-J, Chen Y-L, Liu P-L, Chen J-W. 2006. Antiinflammatory effects of different drugs/agents with antioxidant property on endothelial expression of adhesion molecules. Cardiovasc Haematological Disorders-Drug Targets; 6:279-304
[57] Rosenson RS .2004. Statins in atherosclerosis: lipid-lowering agents with antioxidant capabilities. Atherosclerosis; 173:1–12
[58] Pereira EC, Bertolami MC, Faludi AA, Sevanian A, Abdalla DS. 2004. Antioxidant effect of simvastatin is not enhanced by its association with alpha-tocopherol in hypercholesterolemic patients. Free Radic Biol Med; 37:1440-1448
[59] Prasad K, Kalra J. 1993. Oxygen free radicals and hypercholesterolemic atherosclerosis:effect of vitamin E. Am Heart J; 125(4):135-144.
[60] Prasad K. 2010. Natural products in regression and slowing of progression of atherosclerosis. Curr Pharmaceut Biotechnol; 11:794- 800.
[61] Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett WC. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med; 328:1450-1456.
[62] Velayutham P, Babu A, Liu D. 2008. Green Tea Catechins and Cardiovascular Health: An Update. Curr Med Chem; 15(18):1840–1850
[63] Kleemann R, Verschuren L, Morrison M, Zadelaar S, van Erk MJ, Wielinga PY, Kooistra T. 2011. Anti-inflammatory, anti-proliferative and anti-atherosclerotic effects of quercetin in human in vitro and in vivo models. Ather; 218(1):44-52.